Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat

被引：40
|
作者：
Duvoix, A
Morceau, F
Schnekenburger, M
Delhalle, S
Galteau, MM
Dicato, M
Diederich, M
机构：
[1] Ctr Univ Luxembourg, Lab RCMS, L-1511 Luxembourg, Luxembourg
[2] Univ Nancy 1, Fac Pharm, Lab Thiols & Fonct Cellulaires, F-54000 Nancy, France
来源：
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS | 2003年 / 1010卷
关键词：
curcumin; leukemia; apoptosis;
D O I：
10.1196/annals.1299.071
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Curcumin presents strong antioxidant and anticancer properties. However, molecular mechanisms leading to curcumin-induced cell death are poorly understood. The effect of curcumin was compared in two different leukemia cell lines: K562 and Jurkat. Cell death was induced in both cell lines, and apoptosis pathways were investigated by Western blot analysis. Decreases in pro-caspase 8 and 9 levels were observed. BH3 interacting domain death agonist (Bid) was also cleaved. Jurkat cells appeared to be more sensitive to curcumin, and apoptosis takes place earlier.
引用
收藏
页码：389 / 392
页数：4
相关论文
共 50 条
  • [41] Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
    Niakani, Maryam
    Majd, Ahmad
    Pakzad, Parviz
    Malekinejad, Hassan
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2021, 16 (01) : 26 - 34
  • [42] Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562
    Bruennert, D.
    Bruns, I
    Koch, A.
    Gattermann, N.
    Kronenwett, R.
    Haas, R.
    Neumann, F.
    MEDIZINISCHE KLINIK, 2010, 105 (03) : 210 - 210
  • [43] Ether extract of Streptomyces calvus inhibited growth and induced apoptosis in K562, human leukemia cell
    Amin, Moosavi Mohammad
    Farideh, Ghanbarvand
    Alireza, Dehnad
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S183 - S183
  • [44] Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
    Drullion, C.
    Tregoat, C.
    Lagarde, V.
    Tan, S.
    Gioia, R.
    Priault, M.
    Djavaheri-Mergny, M.
    Brisson, A.
    Auberger, P.
    Mahon, F-X
    Pasquet, J-M
    CELL DEATH & DISEASE, 2012, 3 : e373 - e373
  • [45] Upregulation of stem cell genes in multidrug resistant K562 leukemia cells
    Lehne, Gustav
    Grasmo-Wendler, Unn-Hilde
    Berner, Jeanne-Marie
    Meza-Zepeda, Leonardo A.
    Adamsen, Birgitte Lid
    Flack, Aksel
    Reiner, Andrew
    Clausen, Ole Petter Fraas
    Hovig, Eivind
    Myklebost, Ola
    LEUKEMIA RESEARCH, 2009, 33 (10) : 1379 - 1385
  • [46] Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming
    Aktuna, Acelya Yilmazer
    TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (04) : 260 - 264
  • [47] K562 - A HUMAN-LEUKEMIA CELL-LINE WITH ERYTHROID FEATURES
    GAHMBERG, CG
    ANDERSSON, LC
    SEMINARS IN HEMATOLOGY, 1981, 18 (01) : 72 - 77
  • [48] Antineoplastic activity of free 4-nitrochalcone and encapsulated in poly (thioether-ester) nanoparticles obtained by thiol-ene polymerization in two human leukemia cell lines (Jurkat and K562)
    Feuser, Paulo Emilio
    Matos dos Santos, Paula Christina
    Cordeiro, Arthur Poester
    Stefanes, Natalia Marceli
    Walter, Laura Otto
    Maioral, Mariana Franzoni
    Santos-Silva, Maria Claudia
    Hermes de Araujo, Pedro Henrique
    Sayer, Claudia
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 67
  • [49] Death Receptor 5-Recruited Raft Components Contributes to the Sensitivity of Jurkat Leukemia Cell Lines to TRAIL-induced Cell Death
    Min, Yifan
    Shi, Juan
    Zhang, Yaxi
    Liu, Shilian
    Liu, Yanxin
    Zheng, Dexian
    IUBMB LIFE, 2009, 61 (03) : 261 - 267
  • [50] Undergraduate lab series using the K562 human leukemia cell line: Model for cell growth, death, and differentiation in an advanced cell biology course
    Phelan, Shelley A.
    Szabo, Elizabeth
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2019, 47 (03) : 263 - 271
12345